📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. (2009)

First Author: Antiretroviral Therapy Cohort Collaboration (ART-CC)

Attributed to: Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0b013e3283305a00

PubMed Identifier: 19779320

Publication URI: http://europepmc.org/abstract/MED/19779320

Type: Journal Article/Review

Volume: 23

Parent Publication: AIDS (London, England)

Issue: 16

ISSN: 0269-9370